Jiangxi Tenglong Biological Pharmaceutical Co., Ltd.

Jiangxi Tenglong Biological Pharmaceutical Co., Ltd. was established in 2010 and is located in the Jinxian Industrial Park, Nanchang, covering an area of 50,000 square meters, including a fully enclosed workshop area of 4,000 square meters, with a total investment of 16 million yuan. At present, it has 4 production lines and 9 major dosage forms (small volume injections / large volume injections / oral liquids, powder injections, powders / powders / premixes / granules, disinfectants / insecticides), with complete dosage forms and rich varieties.
The company has a high-quality talent team, with more than 100 employees, advanced animal drug research and development and production technology, a strict GMP quality control management system, unique management methods, leading production equipment and a perfect customer service system. It is a large modern animal health technology enterprise integrating veterinary drug research and development, production and sales. At present, the "Tenglong" series of premium products have been deeply praised and favored by farmers and veterinarians after long-term clinical practice.
In June 2011, "Jiangxi Tenglong Biotechnology Research Institute" cooperated with the College of Animal Science and Technology of Jiangxi Agricultural University to successfully develop the "nano-scale compound vitamin-amino acid-Astragalus polysaccharide" oral liquid product, and was listed by the Ministry of Science and Technology as a "undertaking unit of the Technology Innovation Fund Project for Technology-based Small and Medium-sized Enterprises".
In line with the product concept of "taking high-tech content as the essence", our company already has first-class pharmaceutical equipment and advanced quality control instruments, strictly in accordance with GMP and national standards for production processes and inspection methods. We firmly believe that "today's quality, tomorrow's market".
Adhering to the marketing philosophy of "customer and market demand-oriented" and "win-win as the core", the company implements a market benefit-sharing mechanism and market restriction mechanism, implements the strategy of "symbiosis, win-win and joint maintenance" among manufacturers, distributors and users, and jointly cultivates an orderly market. Maintain the market interests of customers and users to the greatest extent. In the fierce market competition, we will continue to strive, continue to innovate, and develop high-quality new products. The company is committed to creating environmentally friendly and safe veterinary drugs with no harmful residues, long-lasting and quick-acting effects, and making unremitting efforts to solve human food safety, benefiting the people with our high-quality products.